Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus

Journal of Paediatrics and Child Health
Brenda M MorrowAndrew C Argent

Abstract

To describe the clinical presentation and outcomes of hospitalised patients infected with human metapneumovirus (hMPV) and human respiratory syncytial virus (hRSV) in a tertiary hospital in Cape Town, South Africa. hMPV was identified in 17 respiratory specimens submitted for viral studies during the period 2001-2003. These patients' medical folders were retrospectively reviewed for clinical, radiological and laboratory data, together with a convenience sample of 20 hRSV-infected patients. hMPV-infected patients were older than those infected with hRSV (P = 0.04) and required a longer hospital stay (P = 0.02). Presenting clinical signs and symptoms were similar between groups. Fourteen (87.5%) hMPV- and 16 (80%) hRSV-infected patients presented with co-morbid and/or immunosuppressive conditions (P > or = 0.5). The most common abnormalities on chest radiographs in both groups were bronchial wall thickening, focal consolidation and atelectasis. Six (37.5%) hMPV- and 11 (55%) hRSV-infected patients required admission to the paediatric intensive care unit (P > 0.1) with five (31.3%) hMPV- and eight (40%) hRSV-infected patients requiring intubation and ventilation (P > 0.5). Three (18.7%) hMPV-patients and three (15%) hRSV-infected ...Continue Reading

References

May 23, 2002·The Journal of Infectious Diseases·Teresa C T PeretLarry J Anderson
Aug 27, 2002·Emerging Infectious Diseases·Joanne StocktonMaria Zambon
Aug 27, 2002·Emerging Infectious Diseases·Gilles PelletierGuy Boivin
Mar 22, 2003·Lancet·Ab Osterhaus, Ron Fouchier
May 10, 2003·Emerging Infectious Diseases·Diego VicenteEmilio Pérez-Trallero
Jun 5, 2003·Emerging Infectious Diseases·J S Malik PeirisSusan S Chiu
Jun 5, 2003·Emerging Infectious Diseases·Guy BoivinPierre Déry
Oct 9, 2003·Journal of Clinical Microbiology·Nathalie BastienYan Li
Nov 19, 2003·The Journal of Infectious Diseases·Bernadette G van den HoogenRon A M Fouchier
Dec 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shabir A MadhiGuy Boivin
Jan 30, 2004·The New England Journal of Medicine·John V WilliamsJames E Crowe
Mar 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marie-Eve HamelinGuy Boivin
Apr 10, 2004·The Journal of Infectious Diseases·Frank EsperJeffrey S Kahn
Jun 23, 2004·Emerging Infectious Diseases·Joseph BreseeUNKNOWN Asian Rotavirus Surveillance Network

❮ Previous
Next ❯

Citations

Feb 15, 2013·The New England Journal of Medicine·Kathryn M EdwardsUNKNOWN New Vaccine Surveillance Network
Oct 31, 2007·Antimicrobial Agents and Chemotherapy·Céline DeffrasnesGuy Boivin
Jan 6, 2012·Intensive Care Medicine·Marijke J VanspauwenCatharina F M Linssen
Jul 30, 2010·Current Medical Research and Opinion·Robert C WelliverCaroline B Hall
Aug 24, 2017·Pediatric Radiology·Melissa A HilmesJohn V Williams
Apr 26, 2012·The Pediatric Infectious Disease Journal·María Luz García-GarcíaInmaculada Casas
Mar 1, 2012·Current Opinion in Pulmonary Medicine·Tuomas JarttiMaria Söderlund-Venermo
Feb 6, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leigh M HowardDerek J Williams
May 19, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Ani S Abdul GhaniAndrew C Argent
Mar 22, 2007·The Journal of General Virology·Bernadette G van den HoogenRik L de Swart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.